CAC Software vs Study Watch
AI Verdict
Choose CAC Software if…
Choose Imbio's CAC Software if you are a radiologist or cardiologist needing automated, AI-powered analysis of non-contrast chest CT scans to quantify coronary artery calcification. This tool is ideal for quickly generating Agatston scores, arterial age, and 3D visualizations to support risk assessment for coronary artery disease in a clinical setting.
View CAC Software →Choose Study Watch if…
Choose Verily Study Watch if you are a clinical researcher requiring a prescription-only wearable for continuous, non-invasive physiological monitoring in your studies. This device is best suited for collecting long-term, multi-sensor data like ECG and heart rate, which can then be analyzed on Verily's cloud platform to advance research in areas such as cardiology, neurology, or sleep medicine.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CAC Software | Study Watch |
|---|---|---|
| Deployment | Cloud-based (SaaS), integrates with PACS | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CAC SoftwareTool A (CAC Software) integrates seamlessly into existing DICOM viewing workflows, automatically processing images without user intervention and delivering results within the familiar PACS environment. Tool B (Study Watch) requires patient interaction for wearing the device and clinicians to access data via a separate cloud platform, which may introduce additional steps and a learning curve.
Clinical Value
CAC SoftwareTool A (CAC Software) provides immediate, quantifiable diagnostic information for coronary artery disease risk assessment, including Agatston score, arterial age, and calcified lesion mass and volume, directly aiding clinical decision-making. Tool B (Study Watch) is primarily designed for continuous physiological monitoring in clinical research, collecting raw data that, while valuable for studies, is not as immediately actionable for direct diagnosis or risk assessment in routine clinical practice outside of specific AFib monitoring.
Pricing & Value
TieBoth Tool A and Tool B lack publicly available pricing information, making a direct comparison of their cost-effectiveness impossible. Both are enterprise-level solutions, and pricing is typically negotiated based on specific deployments or research partnerships.
Enterprise Readiness
CAC SoftwareTool A (CAC Software) offers flexible deployment options including cloud, on-premise, and partner platforms, and explicitly states HIPAA compliance and FDA clearance without any public controversies. While Tool B (Study Watch) also has FDA clearance and states HIPAA compliance, there are public allegations of BAA breaches and HIPAA violations, which, even if denied, could pose concerns for enterprise adoption.
Innovation
Study WatchTool B (Study Watch) represents a more innovative approach by offering a prescription-only wearable for continuous, multi-modal physiological monitoring, pushing the boundaries of remote data collection and analysis in clinical research. While Tool A (CAC Software) uses AI for efficient image analysis, Tool B's innovation lies in its novel method of acquiring diverse physiological data directly from patients over time.
Support & Docs
CAC SoftwareImbio (Tool A) provides clear contact information for support, including phone numbers and email, and mentions the availability of user manuals and product documentation upon request. Verily (Tool B) offers general support resources for its platform and regulatory information for Study Watch, but less explicit detail on direct product support channels for end-users or comprehensive documentation access outside of specific study contexts.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CAC Software | Study Watch |
|---|---|---|
| Name | CAC Software | Study Watch |
| Description | Automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). | Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. |
| Key Functionality | Automated image post-processing for coronary artery calcification, quantification of calcification, outputs Agatston score, arterial age, calcified lesion mass and volume, provides 3D visualizations and annotated images, non-invasive analysis from non-contrast chest CT scans, integrates into existing DICOM viewing workflow, supports risk assessment for coronary artery disease, deep-learning based analysis. | Continuous physiological monitoring, multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), long battery life (up to one week), internal data storage and encryption, cloud-based data processing with algorithms and machine learning, on-demand single-channel ECG, irregular pulse monitor, E-ink display for minimal power consumption. |
| Categories | Cardiology AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Radiology | Cardiology, Neurology, Sleep Medicine |
Videos
Demos, reviews, and walkthroughs featuring CAC Software and Study Watch.